Anzeige
Mehr »
Login
Mittwoch, 29.05.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 529882 | ISIN: US2183521028 | Ticker-Symbol: HTD
Tradegate
28.05.24
14:39 Uhr
30,100 Euro
+0,990
+3,40 %
1-Jahres-Chart
CORCEPT THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
CORCEPT THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
28,69029,26012:45
28,69029,26012:41

Aktuelle News zur CORCEPT THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCorcept rises as hormone disorder drug succeeds in late-stage study1
DiWhy Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday?1
DoCORCEPT THERAPEUTICS INC - 8-K, Current Report2
16.05.Risk adjusted net present value: What is the current valuation of Corcept Therapeutics's Miricorilant?1
02.05.The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts2
02.05.Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates1
02.05.Earnings call: Corcept Therapeutics raises 2024 revenue guidance2
02.05.Corcept Therapeutics Inc reports results for the quarter ended in March - Earnings Summary6
01.05.CORCEPT THERAPEUTICS INC - 10-Q, Quarterly Report1
01.05.Corcept Therapeutics Incorporated: Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update15MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe...
► Artikel lesen
24.04.Corcept Therapeutics Incorporated: Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call1
23.04.Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study2
22.04.Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter1
22.04.Corcept falls on limited data from late-stage trial of Cushing's syndrome drug1
22.04.Corcept falls after phase 3 results on Cushing's candidate doesn't include some data4
17.04.CORCEPT THERAPEUTICS INC - 8-K, Current Report3
16.04.Corcept (CORT) Completes Enrollment in Phase II ALS Study1
09.04.Corcept (CORT) Completes Enrollment in Ovarian Cancer Study3
25.03.Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?1
16.02.Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow4
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3